Insufficient scRNA-seq data for expression of ARHGAP19 at single-cell level.
Insufficient scRNA-seq data for expression of ARHGAP19 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 1563.40 | 458 / 459 | 100% | 11.01 | 1113 / 1118 |
prostate | 100% | 1084.04 | 245 / 245 | 99% | 7.74 | 498 / 502 |
brain | 99% | 834.70 | 2626 / 2642 | 100% | 11.47 | 703 / 705 |
esophagus | 100% | 955.33 | 1443 / 1445 | 98% | 7.68 | 180 / 183 |
thymus | 100% | 827.84 | 651 / 653 | 98% | 17.40 | 595 / 605 |
lung | 100% | 1187.26 | 576 / 578 | 98% | 8.17 | 1136 / 1155 |
uterus | 100% | 1342.63 | 170 / 170 | 98% | 9.99 | 449 / 459 |
bladder | 100% | 963.05 | 21 / 21 | 98% | 6.95 | 492 / 504 |
skin | 100% | 1343.05 | 1803 / 1809 | 95% | 11.19 | 448 / 472 |
intestine | 100% | 1140.97 | 966 / 966 | 94% | 5.54 | 495 / 527 |
stomach | 99% | 753.04 | 355 / 359 | 94% | 5.00 | 269 / 286 |
kidney | 100% | 1054.27 | 89 / 89 | 91% | 5.39 | 820 / 901 |
adrenal gland | 95% | 613.04 | 246 / 258 | 89% | 4.52 | 205 / 230 |
ovary | 100% | 1671.56 | 180 / 180 | 83% | 3.73 | 355 / 430 |
pancreas | 84% | 383.37 | 276 / 328 | 97% | 5.59 | 173 / 178 |
liver | 92% | 456.55 | 208 / 226 | 80% | 3.81 | 325 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 18.79 | 29 / 29 |
spleen | 100% | 2972.71 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.62 | 1 / 1 |
adipose | 100% | 1072.41 | 1199 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 11.39 | 44 / 45 |
peripheral blood | 97% | 2367.08 | 901 / 929 | 0% | 0 | 0 / 0 |
heart | 93% | 552.58 | 805 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 93% | 559.48 | 1238 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 73% | 3.06 | 58 / 80 |
muscle | 63% | 252.12 | 506 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007165 | Biological process | signal transduction |
GO_0051056 | Biological process | regulation of small GTPase mediated signal transduction |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
GO_0005096 | Molecular function | GTPase activator activity |
Gene name | ARHGAP19 |
Protein name | Rho GTPase-activating protein 19 (Rho-type GTPase-activating protein 19) ARHGAP19 Rho GTPase activating protein 19 |
Synonyms | |
Description | FUNCTION: GTPase activator for the Rho-type GTPases by converting them to an inactive GDP-bound state. . |
Accessions | Q14CB8 R4GMS4 R4GNI4 A0A2X0U4I8 ENST00000358531.9 [Q14CB8-1] ENST00000371027.5 [Q14CB8-3] ENST00000492211.5 ENST00000358308.7 [Q14CB8-6] ENST00000466484.1 |